25P-NBOMe

25P-NBOMe (2C-P-NBOMe, NBOMe-2C-P) is a derivative of the phenethylamine 2C-P. It acts in a similar manner to related compounds such as 25I-NBOMe, which are potent agonists at the 5-HT_2A receptor.^[2][3] 25P-NBOMe has been sold as a drug and produces similar effects in humans to related compounds such as 25I-NBOMe and 25C-NBOMe.

25P-NBOMe

Legal status
Legal status	BR: Class F2 (Prohibited psychotropics)[1] DE: NpSG (Industrial and scientific use only) UK: Class A
Identifiers
IUPAC name 2-(4-propyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
CAS Number	1391489-07-8
PubChem CID	118796470
ChemSpider	52085310 Y
UNII	71505RK15Z
CompTox Dashboard (EPA)	DTXSID801014185
Chemical and physical data
Formula	C21H29NO3
Molar mass	343.467 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCCC1=CC(OC)=C(CCNCC2=C(OC)C=CC=C2)C=C1OC
InChI InChI=1S/C21H29NO3/c1-5-8-16-13-21(25-4)17(14-20(16)24-3)11-12-22-15-18-9-6-7-10-19(18)23-2/h6-7,9-10,13-14,22H,5,8,11-12,15H2,1-4H3 Y Key:QHEBYIJRKGDFGH-UHFFFAOYSA-N Y

Legality

United Kingdom

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.^[4]

See also

• 25E-NBOMe (NBOMe-2C-E)
• 25D-NBOMe (NBOMe-2C-D)
• 25I-NBOMe (NBOMe-2C-I)
• 25B-NBOMe (NBOMe-2C-B)
• 25C-NBOMe (NBOMe-2C-C)
• 25TFM-NBOMe (NBOMe-2C-TFM)
• 25T7-NBOMe (NBOMe-2C-T-7)

References

1. Anvisa (2023-07-24). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-07-25). Archived from the original on 2023-08-27. Retrieved 2023-08-27.
2. Hansen M, Phonekeo K, Paine JS, Leth-Petersen S, Begtrup M, Bräuner-Osborne H, Kristensen JL (March 2014). "Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists". ACS Chemical Neuroscience. 5 (3): 243–9. doi:10.1021/cn400216u. PMC 3963123. PMID 24397362.
3. Hansen M (2010-12-16). Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain (Ph.D. thesis). University of Copenhagen. doi:10.13140/RG.2.2.33671.14245.
4. "The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014". UK Statutory Instruments 2014 No. 1106. www.legislation.gov.uk.